Internal limiting membrane: Ultrastructural relationships, with clinical implications for macular hole healing

Canadian Journal of Ophthalmology

Volumn 39, Issue 3, 2004, Pages 251-259

  Rezende, Flávio A ^a,b   Kapusta, Michael A ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Internal limiting membrane; Macular hole; Posterior vitreous detachment; Retinal glial cells; Vitreoretinal interface

Indexed keywords

COLLAGEN TYPE 4; GLIAL FIBRILLARY ACIDIC PROTEIN; INDOCYANINE GREEN;

CANADA; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EPIRETINAL MEMBRANE; EXTRACELLULAR MATRIX; FEMALE; GLIA CELL; HEALING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDLINE; MUELLER CELL; REOPERATION; RETINA; RETINA INTERNAL LIMITING MEMBRANE; RETINA MACULA HOLE; RETROSPECTIVE STUDY; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT FAILURE; VITRECTOMY;

EID: 2442634030     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(04)80122-4     Document Type: Article

References (48)

1. Tornambe PE, Poliner LS, Cohen RG. Definition of macular hole surgery end points: elevated/open, flat/open, flat/closed [letter]. Retina 1998;18:286-7.
2. Huang SS, Wendel RT. Vitreous surgery for full-thickness macular holes. In: Madreperla SA, McCuen BW, editors. Macular hole: pathogenesis, diagnosis, and treatment. Boston: Butterworth-Heinemann; 1999. p. 95-104.
3. Brooks HL Jr. Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 2000;107:1939-48.
4. Kim JW, Freeman WR, Azen SP, El-Haig W, Klein DJ, Bailey IL, and the Vitrectomy for Macular Hole Study Group. Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Am J Ophthalmol 1996;121:605-14.
5. Freeman WR, Azen SP, Kim JW, El-Haig W, Mishell DR 3rd, Bailey IL, for the Vitrectomy for Macular Hole Study Group. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. Arch Ophthalmol 1997;115:11-21.
6. 2 for the treatment of full-thickness macular holes: a prospective randomized study. Ophthalmology 1992;99:1162-73.
7. Imai M, Iijima H, Gotoh T, Tsukahara S. Optical coherence tomography of successfully repaired idiopathic macular holes. Am J Ophthalmol 1999;128:621-7.
8. Kwok AKH, Li WWY, Pang CP, Lai TYY, Yam GHF, Chan NR, et al. Indocyanine green staining and removal of internal limiting membrane in macular hole surgery: histology and outcome. Am J Ophthalmol 2001;132:178-83.
9. Rice TA. Internal limiting membrane removal in surgery for full-thickness macular holes. In: Madreperla SA, McCuen BW, editors. Macular hole: pathogenesis, diagnosis, and treatment. Boston: Butterworth-Heinemann; 1999. p. 125-46.
10. Jumper JM, Gallemore RP, McCuen BW 2nd, Toth CA. Features of macular hole closure in the early postoperative period using optical coherence tomography. Retina 2000;20:232-7.
11. Sebag J. Vitreous anatomy and the vitreomacular interface. In: Madreperla SA, McCuen BW 2nd, editors. Macular hole: pathogenesis, diagnosis, and treatment. Boston: Butterworth-Heinemann; 1999. p. 1-23.
12. Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res 2000;19(3):323-44.
13. Hogan MJ, Alvarado JA, Weddell JE. Vitreous. In: Hogan MJ, Alvarado JA, Weddell JE, editors. Histology of the human eye: an atlas and textbook. Philadelphia: W.B. Saunders; 1971. p. 607-37.
14. Snead MP, Snead DRJ, Richards AJ, Harrison JB, Poulson AV, Morris AHC, et al. Clinical, histological and ultrastructural studies of the posterior hyaloid membrane. Eye 2002;16:447-53.
15. Deguine V, Labat-Robert J, Ferrari P, Pouliquen Y, Menasche M, Robert L. Vieillissement du vitré oculaire. Rôle de la glycation et des radicaux libres. Path Biol 1997;45(4):321-30.
16. Lazarus HS, Hageman GS. In situ characterization of the human hyalocyte. Arch Ophthalmol 1994;112:1356-62.
17. Foos R, Roth AM. Surface structure of the optic nerve head: 2. Vitreopapillary attachments and posterior vitreous detachment. Am J Ophthalmol 1973;76(5):662-71.
18. Bishop PN, Takanosu M, le Goff M, Mayne R. The role of the posterior ciliary body in the biosynthesis of vitreous humour. Eye 2002;16:454-60.
19. Heegaard S. Morphology of the vitreoretinal border region. Acta Ophthalmol Scand Suppl 1997;222:1-31.
20. Cooper GM. The cell: a molecular approach. 2nd ed. Sunderland (MA): Sinauer Associates; 2000. Chap 3. Available: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowSection&rid= cooper.section.1808 (accessed 2004 Feb 1).
21. Foos R. Vitreoretinal juncture; topographical variations. Invest Ophthalmol 1972;11(10):801-8.
22. Kishi S, Demaria C, Shimizu K. Vitreous cortex remnants at the fovea after spontaneous vitreous detachment. Int Ophthalmol 1986;9:253-60.
23. Spaide RF, Wong D, Fisher Y, Goldbaum M. Correlation of vitreous attachment and foveal deformation in early macular hole states. Am J Ophthalmol 2002;133:226-9.
24. Kakehashi A, Schepens CL, Trempe CL. Vitreomacular observations: I. Vitreomacular adhesion and hole in the premacular hyaloid. Ophthalmology 1994;101:1515-21.
25. Uchino E, Uemura A, Ohba N. Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography. Arch Ophthalmol 2001;119:1475-9.
26. Sebag J. Age-related differences in the human vitreoretinal interface. Arch Ophthalmol 1991;109:966-71.
27. Scott JD. Future perspectives in primary retinal detachment repair. Eye 2002;16:349-52.
28. Li K, Wong D, Hiscott P, Stanga P, Groenewald C, McGalliard J. Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings. Br J Ophthalmol 2003;87:216-9.
29. Kakehashi A, Schepens CL, Trempe CL. Vitreomacular observations: II. Data on the pathogenesis of idiopathic macular breaks. Graefes Arch Clin Exp Ophthalmol 1996;234:425-33.
30. Gandorfer A, Putz E, Welge-Lüssen U, Grüterich M, Ulbig M, Kampik A. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol 2001;85:6-10.
31. Snead MP, Snead DRJ, Mahmood AS, Scott JD. Vitreous detachment and the posterior hyaloid membrane: a clinicopathological study. Eye 1994;8:204-9.
32. Kohno T, Sorgente N, Ishibashi T, Goodnight R, Ryan SJ. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci 1987;28:506-14.
33. Ramírez JM, Triviño A, Ramírez AI, Salazar JJ, García-Sánchez J. Structural specializations of human retinal glial cells. Vision Res 1996;36(14):2029-36.
34. Ramírez JM, Ramírez AI, Salazar JJ, de Hoz R, Triviño A. Changes of astrocytes in retinal ageing and age-related macular degeneration. Exp Eye Res 2001;73:601-15.
35. Gass JDM. Müller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacular retinoschisis. Arch Ophthalmol 1999;117:821-3.
36. Claudepierre T, Dalloz C, Mornet D, Matsumura K, Sahel J, Rendon A. Characterization of the intermolecular associations of the dystrophin-associated glycoprotein complex in retinal Müller cells. J Cell Sci 2000;113:3409-17.
37. Claudepierre T, Mornet D, Pannicke T, Forster V, Dalloz C, Bolaños F, et al. Expression of Dp71 in Müller glial cells: a comparison with utrophin- and dystrophin-associated proteins. Invest Ophthalmol Vis Sci 2000;41:294-304.
38. Shyy JYJ, Chien S. Role of integrins in cellular responses to mechanical stress and adhesion. Curr Opin Cell Biol 1997;9:707-13.
39. Brem RB, Robbins SG, Wilson DJ, O'Rourke LM, Mixon RN, Robertson JE, et al. Immunolocalization of integrins in the human retina. Invest Ophthalmol Vis Sci 1994;35(9):3466-74.
40. 1 integrin in human eye diseases involving vitreoretinal traction. FASEB J 1993;7:1401-6.
41. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
42. Funata M, Wendel RT, de la Cruz Z, Green WR. Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina 1992;12:289-98.
43. Madreperla SA, Geiger GL, Funata M, de la Cruz Z, Green WR. Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology 1994;101:682-6.
44. Yamada E. Some structural features of the fovea centralis in the human retina. Arch Ophthalmol 1969;82:151-9.
45. Yamana T, Kita M, Ozaki S, Negi A, Honda Y. The process of closure of experimental retinal holes in rabbit eyes. Graefes Arch Clin Exp Ophthalmol 2000;238:81-7.
46. Bishop P. The biochemical structure of mammalian vitreous. Eye 1996;10:664-70.
47. Scott JE. The chemical morphology of the vitreous. Eye 1992;6:553-5.
48. Aumailley M, Gayraud B. Structure and biological activity of the extracellular matrix. J Mol Med 1998;76:253-65.